Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
September 27, 2018
Kuros Reports First Patient Treated in Randomized Controlled Trial of MagnetOs in Spinal Fusion
SCHLIEREN (ZURICH), Switzerland, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) today announced that the first patient has been treated in an investigator-led multicenter ...
September 27, 2018
Inventiva: First-half 2018 financial results and business update
Daix (France), September 27, 2018 - Inventiva S.A. ("Inventiva" or the "Company"), a biopharmaceutical company developing innovative therapies in nonalcoholic steatohepatitis (NASH), systemic sclerosis (SSc) ...
September 27, 2018
HTG Molecular Announces Extension to Precision Diagnostic Partnership (PDP) Program Three for Companion Diagnostic Submission
TUCSON, Ariz., Sept. 27, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (“HTG”), a provider of instruments, reagents, and services for molecular profiling applications, ...
September 26, 2018
HTG Molecular to Present a Corporate Overview at the Cantor Fitzgerald Global Healthcare Conference
TUCSON, Ariz., Sept. 26, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, ...
September 26, 2018
Genkyotex Exceeds Patient Enrollment Target in its Phase 2 Trial with GKT831 for Primary Biliary Cholangitis
Regulatory News: Genkyotex (GKTX.PA) (GKTX.PA) (Euronext Paris & Brussels: FR00011790542 – GKTX), a biopharmaceutical company and the leader in NOX therapies, announces today the completion of ...
September 26, 2018
Celyad Appoints Carri Duncan as Vice-President Corporate Development & Communications
MONT-SAINT-GUIBERT, Belgium, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a clinical-stage biopharmaceutical company focused on the development of ...
September 26, 2018
EDAP TMS SA : Houston Methodist Medical Center Research Study Sheds Positive Light on Use of HIFU for Localized Prostate Cancer
AUSTIN, TX - LYON, France, September 26, 2018 - EDAP TMS (EDAP) today announced the results of a study conducted at Houston Methodist Medical Center ...
September 26, 2018
Foamix Pharmaceuticals to Participate in the Cantor Fitzgerald Global Healthcare Conference
REHOVOT, Israel and BRIDGEWATER, N.J., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX), a clinical-stage specialty pharmaceutical company focused on developing and commercializing ...
September 26, 2018
Aimmune Therapeutics to Present at the Cantor Global Healthcare Conference on Wednesday, October 3
BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that President and CEO Jayson Dallas, M.D., will ...
September 26, 2018
Molecular Templates to Present at the Ladenburg Thalmann and Cantor Healthcare Conferences
AUSTIN, Texas, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (MTEM), a clinical-stage oncology company focused on the discovery and development of the company’s ...
September 26, 2018
AIT Therapeutics to Present at the Ladenburg 4th Annual Healthcare Conference
NEW YORK, Sept. 26, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ...
September 26, 2018
Opiant Pharmaceuticals to Present at the Cantor Global Healthcare Conference
SANTA MONICA, Calif., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, ...
September 26, 2018
Zosano Pharma Enters Into Capital Equipment Lease Agreement With Trinity Capital Investment
FREMONT, Calif., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company developing and commercializing therapies that deliver ...
September 26, 2018
Novus Therapeutics to Present at the Ladenburg Thalmann 2018 Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Novus Therapeutics, Inc. (NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (“ENT”), ...
September 26, 2018
Kitov to Present Data on NT219 in Combination with Keytruda® and Erbitux® at AACR International Cancer Immunotherapy Conference
TEL AVIV, Israel, Sept. 26, 2018 (GLOBE NEWSWIRE) --  Kitov Pharma (NASDAQ/TASE: KTOV), an innovative biopharmaceutical company, today announced that Hadas Reuveni, Ph.D., Chief Technology ...
September 26, 2018
Genkyotex Announces First-Half 2018 Financial Results
Regulatory News:Genkyotex (Euronext Paris & Brussels: FR00011790542 – GKTX) (GKTX.PA) (GKTX.PA), a biopharmaceutical company and the leader in NOX therapies, announces its consolidated financial results ...
September 25, 2018
Celyad to Participate at Upcoming Healthcare Conferences
MONT-SAINT-GUIBERT, Belgium, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a clinical-stage biopharmaceutical company focused on the development of ...
September 25, 2018
Kamada to Present Corporate Overview at the Cantor Fitzgerald Global Healthcare Conference
REHOVOT, Israel, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ and TASE: KMDA), a plasma-derived protein therapeutics company, announced today that Amir London, Chief ...
September 25, 2018
Arcturus Therapeutics to Present at October Investor Conferences
SAN DIEGO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT), a leading RNA medicines company, today announced that Joseph Payne will present at ...
September 25, 2018
BioTime to Participate on Industry Perspectives Roundtable at NEI Audacious Goals in Regenerative Medicine Workshop: Pathways for Retinal Cell Replacement Therapies
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that Francois Binette, Senior Vice President and BioTime’s ...
Page 36 of 138